Why CVS and Walmart Are Parting Ways
CVS shares dipped on Tuesday after the company announced that it would be parting ways with the megastore Walmart.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 110
Where Does Aptinyx Go Next After Disappointing Midstage Results for Pain Treatment?
Aptinyx shares were absolutely crushed on Wednesday after the firm reported midstage results from its clinical study in patients with painful diabetic peripheral neuropathy.
Why CVS and Walmart Are Parting Ways
CVS shares dipped on Tuesday after the company announced that it would be parting ways with the megastore Walmart.
Major Pharma Sees Fading Short Interest
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Major Biotechs Scare Off Short Sellers
The December 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Flu Season Could Cost Employers $17 Billion
The 2018-2019 flu season is predicted to cost U.S. businesses some $17 billion in lost productivity. Here are some steps employees and employers can take to minimize the impact.
Why the FDA Is Coming Down on Akorn
Akorn shares dipped on Wednesday after the company received a warning letter from the FDA regarding its Decatur, Illinois, manufacturing facility.
Moderna Makes Big Post-IPO Strides With Pipeline Update
Moderna shares made a handy gain early Tuesday after the company announced updates to several of its immuno-oncology and rare disease programs and outlined its 2019–2020 corporate objectives.
Alector Files for IPO
Clinical-stage biopharmaceutical company Alector has filed with the SEC for its initial public offering.
Are Loxo Shareholders Getting Enough in the Buyout?
Loxo shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly. The transaction is not subject to any financing condition and is expected to…
Why Axsome Therapeutics Depression Study Is All Smiles
Axsome shares absolutely exploded on Monday after the company announced that its midstage trial in patients with major depressive disorder met its primary endpoint.
Poseida Therapeutics Gears Up for IPO
Clinical-stage biopharmaceutical company Poseida Therapeutics has filed with the SEC regarding its initial public offering.
Major Biopharma Catalysts Coming in the First Quarter of 2019
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the first quarter of 2019.
Ultragenyx Wins Big in Blood Sugar Study
Ultragenyx Pharma shares made a handy gain to close out the week after the company announced positive results from its midstage trial for the treatment of glycogen storage disease type Ia.
6 Top Health Care Picks Set to Scream Higher in 2019
A prominent health care analyst has identified his top health care stock picks for 2019, and some are somewhat speculative.